Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Begum

Showing results (351-360 of 355) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 355 results.
The Lancet. Infectious Diseases|March 19, 2018
Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trialFirdausi Qadri, Mohammad Ali, Julia Lynch, et al.
The New England Journal of Medicine|May 5, 2016
Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in BangladeshFirdausi Qadri, Thomas F Wierzba, Mohammad Ali, et al.
Lancet (London, England)|July 13, 2015
Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trialFirdausi Qadri, Mohammad Ali, Fahima Chowdhury, et al.
BMJ Oncology|January 31, 2025
Use of immunosuppression and subsequent cancer incidence: cohort studyJeanine M Buchanich, Craig W Newcomb, Terri L Washington, et al.
Ophthalmology|July 27, 2023
Use of Immunosuppression and the Risk of Subsequent Overall or Cancer MortalityJohn H Kempen, Craig W Newcomb, Terri L Washington, et al.
Pageof 36

Showing results (351-360 of 355) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 355 results.
The Lancet. Infectious Diseases|March 19, 2018
Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trialFirdausi Qadri, Mohammad Ali, Julia Lynch, et al.
The New England Journal of Medicine|May 5, 2016
Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in BangladeshFirdausi Qadri, Thomas F Wierzba, Mohammad Ali, et al.
Lancet (London, England)|July 13, 2015
Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trialFirdausi Qadri, Mohammad Ali, Fahima Chowdhury, et al.
BMJ Oncology|January 31, 2025
Use of immunosuppression and subsequent cancer incidence: cohort studyJeanine M Buchanich, Craig W Newcomb, Terri L Washington, et al.
Ophthalmology|July 27, 2023
Use of Immunosuppression and the Risk of Subsequent Overall or Cancer MortalityJohn H Kempen, Craig W Newcomb, Terri L Washington, et al.
Pageof 36